CorMedix Inc (NASDAQ: CRMD) is 77.16% higher on its value in year-to-date trading and has touched a low of $3.61 and a high of $13.99 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CRMD stock was last observed hovering at around $13.98 in the last trading session, with the day’s gains setting it 0.37%.
Currently trading at $14.35, the stock is 14.76% and 44.67% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.74 million and changing 2.65% at the moment leaves the stock 48.84% off its SMA200. CRMD registered 170.75% gain for a year compared to 6-month gain of 48.24%. The firm has a 50-day simple moving average (SMA 50) of $9.9188 and a 200-day simple moving average (SMA200) of $9.64135.
The stock witnessed a 19.29% loss in the last 1 month and extending the period to 3 months gives it a 33.74%, and is 12.99% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.76% over the week and 2.84% over the month.
CorMedix Inc (CRMD) has around 65 employees, a market worth around $973.29M and $82.55M in sales. Current P/E ratio is 63.66 and Fwd P/E is 9.51. Profit margin for the company is 20.81%. Distance from 52-week low is 297.51% and 2.57% from its 52-week high. The company has generated returns on investments over the last 12 months (14.91%).
with sales reaching $29.88M over the same period.The EPS is expected to grow by 365.00% this year, but quarterly earnings will post 231.77% year-over-year. Quarterly sales are estimated to grow 3,606.46% in year-over-year returns.
CorMedix Inc (CRMD) Top Institutional Holders
186.0 institutions hold shares in CorMedix Inc (CRMD), with institutional investors hold 37.53% of the company’s shares. The shares outstanding are 67.71M, and float is at 65.96M with Short Float at 12.81%. Institutions hold 37.09% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 3.55 million shares valued at $15.39 million. The investor’s holdings represent 6.167% of the CRMD Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 2.9 million shares valued at $12.57 million to account for 5.0373 of the shares outstanding. The other top investors are ELLIOTT INVESTMENT MANAGEMENT L.P. which holds 1.55 million shares representing 2.6909% and valued at over $6.71 million, while NOMURA HOLDINGS INC holds 2.4682 of the shares totaling 1.42 million with a market value of $6.16 million.
CorMedix Inc (CRMD) Insider Activity
The most recent transaction is an insider purchase by Mistry Erin, the company’s EVP, Chief Commercial Officer. SEC filings show that Mistry Erin bought 1,500 shares of the company’s common stock on Oct 31 ’24 at a price of $9.99 per share for a total of $14985.0. Following the purchase, the insider now owns 52011.0 shares.
CorMedix Inc disclosed in a document filed with the SEC on Nov 14 ’24 that Hurlburt Elizabeth (EVP) sold a total of 140,027 shares of the company’s common stock. The trade occurred on Nov 14 ’24 and was made at $11.18 per share for $1.57 million. Following the transaction, the insider now directly holds 45397.0 shares of the CRMD stock.
Still, SEC filings show that on Nov 14 ’24, Hurlburt Elizabeth (Officer) Proposed Sale 140,027 shares at an average price of $11.12 for $1.56 million. The insider now directly holds shares of CorMedix Inc (CRMD).
